Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹788 Cr₹800 Cr₹1,063 Cr₹337 Cr₹361 Cr

What is the latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of GLENMARK PHARMACEUTICALS is ₹788 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹788 Cr
Mar2025₹800 Cr
Mar2024₹1,063 Cr
Mar2023₹337 Cr
Mar2022₹361 Cr

How is Contingent Liabilities of GLENMARK PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2026 ₹788 Cr
-1.56
Mar2025 ₹800 Cr
-24.74
Mar2024 ₹1,063 Cr
215.81
Mar2023 ₹337 Cr
-6.81
Mar2022 ₹361 Cr -

Compare Contingent Liabilities of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹69,539.7 Cr 1% 13.1% 27.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,180.0 Cr 1.6% -1% 22.2% Stock Analytics
DIVIS LABORATORIES ₹243,302.0 Cr 1.7% 10.1% 49.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,623.0 Cr 1.5% -1.2% 38.2% Stock Analytics
CIPLA ₹114,554.0 Cr 0.7% -3.5% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,741.0 Cr -1.3% 0.1% -7.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1%

13.1%

27.5%

SENSEX

-0.9%

-1.5%

-5.8%


You may also like the below Video Courses